BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Jun 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-05-26

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-26	Common Stock	M	15000	$26.49	Acquired	130914	Direct
2016-05-26	Common Stock	S	10000	$88.04	Disposed	120914	Direct
2016-05-26	Common Stock	S	5000	$87.34	Disposed	115914	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-26	Common Stock (Right to buy Common Stock)	$26.49	M	15000	Disposed	2021-05-11	Common Stock (15000)	Direct

Footnotes

F1: All shares were sold at the same price

F2: The price in column 4 is a weighed average price. The price actually received ranged from $86.50 to $88.34. The reporting person will provide to the issuer, and security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.